Testing safety of an embolectomy catheter used during clot surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study follows patients who are having surgery to remove a blood clot in an artery or vein and where a specific clot-removal catheter (the LeMaitre TufTex Single Lumen) is used. It aims to confirm how well the device works and monitor safety outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your doctor must be planning surgery to remove an artery or vein clot, using this specific catheter.
- You must be diagnosed with an embolus (clot that traveled) or a thrombus (clot that formed).
- Thrombolytic (clot-busting) medicine must have failed or cannot be used for you.
- You must be able and willing to sign informed consent for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a specific over-the-wire catheter (TufTex) is safe and works well when doctors remove blood clots (embolus/thrombus) during surgery. You might join if you’re having a planned clot-removal procedure and other clot-dissolving medicines have not worked or can’t be used.
This study tests a special catheter (a thin tube) designed to remove blood clots from large arteries in the brain during a stroke. The goal is to see if it is safe and effective at restoring blood flow.
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
This trial studies a clot-removal device used through a catheter to treat acute pulmonary embolism (a blood clot in the lungs). It aims to see if the device can safely remove clots and improve outcomes compared with standard care planning.
This trial tests a new catheter (Toro 88 Super Bore) for removing blood clots in people having a severe stroke within the last 24 hours. It may help if you need a mechanical thrombectomy.
Hear when a new Arterial Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.